by dyadic | Mar 18, 2020 | Press Releases
JUPITER, FL / ACCESSWIRE / March 18, 2020 / Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate...
by dyadic | Mar 16, 2020 | Press Releases
JUPITER, FL / ACCESSWIRE / March 16, 2020 / Dyadic International, Inc. (“Dyadic”) (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to speed up the development, lower production...
by dyadic | Feb 25, 2020 | Press Releases
NES-ZIONA, ISRAEL and JUPITER, FL / ACCESSWIRE / February 25, 2020 / Dyadic International, Inc. (”Dyadic”) (NASDAQ:DYAI), a global biotechnology company announced today that they are joining the global fight against the coronavirus outbreak by...
by dyadic | Feb 24, 2020 | Press Releases
Further Extends Company’s Biologic Market Opportunities JUPITER, FL / ACCESSWIRE / February 24, 2020 / Dyadic International, Inc. (“Dyadic”) (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1...
by dyadic | Feb 5, 2020 | Press Releases
JUPITER, FL / ACCESSWIRE / February 5, 2020 / Dyadic International, Inc. (the “Company”) (NASDAQ:DYAI), today announced that its President and Chief Executive Officer, Mark Emalfarb, will be presenting at the following investor conferences: BIO CEO &...
by dyadic | Jan 31, 2020 | Press Releases
JUPITER, FL / ACCESSWIRE / January 31, 2020 / Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to...
